Market
Boldo extract is a niche botanical ingredient derived from boldo leaf (Peumus boldus Molina), a species native to central and southern Chile. Commercial use centers on leaf-based products for infusions and for extraction of bioactive and aromatic constituents, with overseas market presence reported alongside domestic use. In regulated herbal-medicinal contexts (e.g., the EU), recognized preparations include dried/fragmented leaf and dry extracts produced via aqueous extraction and solvent evaporation, shaping buyer expectations for traceability and manufacturing controls. Global trade classification for boldo extract commonly falls within the HS Chapter 13 framework for “vegetable saps and extracts,” but product-level trade flows are difficult to isolate from broader extract categories without dedicated customs line detail.
Major Producing Countries- 칠레Source species is native to central & southern Chile; leaf is the principal commercial product used domestically and in overseas markets.
Major Exporting Countries- 칠레Primary origin associated with international commercial leaf/extract supply given endemic/native range of the source species.
Risks
Supply Concentration HighBoldo extract supply is structurally concentrated because the source species (Peumus boldus) is native to central and southern Chile and the leaf is the primary commercial product used in overseas markets; disruptions affecting Chilean forest regions (e.g., drought and recurring wildfires) can quickly tighten global availability for this niche ingredient.Contract diversified supplier base (multiple Chilean regions/collectors), implement WHO-aligned GACP for collection, maintain safety stock for long-lead shipments, and qualify standardized extract specifications with multiple processors.
Regulatory Compliance MediumIn regulated herbal-medicinal contexts, boldo-leaf preparations are tied to traditional-use indications and include explicit contraindications (e.g., bile-duct obstruction, cholangitis, liver disease, gallstones), raising compliance and labeling risk for products positioned with health claims.Align product claims, labeling, and contraindication warnings with target-market rules; maintain documentation on preparation type (e.g., aqueous dry extract) and intended use category (food supplement vs medicinal).
Quality Assurance MediumAs a botanical extract, boldo extract is sensitive to variability in raw-material sourcing and processing method (dry leaf vs aqueous dry extract), increasing risk of inconsistent composition and contamination if starting material is not tightly specified and controlled.Specify botanical identity (Peumus boldus), require COAs with marker/identity testing (e.g., boldine presence), and apply GMP for herbal medicines plus contaminant controls (micro, heavy metals, pesticides) appropriate to the destination market.
Sustainability- Supply-chain dependence on a source species endemic to Chile and associated with native Mediterranean-type sclerophyll forest and shrublands creates ecosystem-linked sourcing and traceability pressures.
- Increasing drought and wildfire exposure in Chilean forest regions can disrupt harvesting access, degrade resource quality, and introduce supply volatility for wild- or semi-wild-sourced leaf inputs.
FAQ
What plant is boldo extract derived from?Boldo extract is derived from boldo leaf, which is the leaf of the plant Peumus boldus Molina.
Where is the source plant (Peumus boldus) native to?Peumus boldus is native to central and southern Chile.
What preparation methods are recognized for boldo leaf extracts in the EU herbal-medicinal context?The EMA’s herbal assessment describes preparations made by drying and comminuting the leaves, or by extracting plant material with water and then evaporating the solvent to obtain a dry extract.
What are notable contraindications highlighted for boldo leaf preparations in EU herbal-medicinal summaries?The EMA summary notes that boldo leaf medicines must not be taken by patients with obstruction of the bile duct, cholangitis, liver disease, gallstones, or other bile-duct disorders that require medical supervision.